Sheba Medical Center
Non-Hodgkin's lymphoma treatment cost in Israel typically involves specialized care, where a bone marrow transplantation ranges from $144,000 to $225,600 and chemotherapy runs from $2,400 to $5,500. Total expenses depend on the lymphoma subtype, disease stage, and the chosen therapeutic protocol. Patients can expect 30-80% savings compared to the United States. Tel Aviv, Jerusalem, and Ramat Gan are the primary cities for this treatment.
Typical Non-Hodgkin's Lymphoma Treatment Costs in Israel
Bookimed Expert Insight: Advanced or refractory cases benefit most from centers specializing in CAR T-cell therapy and complex transplants. Sourasky Medical Center (Ichilov) reports a 90% oncology success rate with specialists like Dr. Herishanu Yair. For pediatric patients, Hadassah Medical Center is a premier choice. Dr. Polina Stepensky has performed over 3,500 transplants there, offering world-class expertise for rare blood cancers.
| Israel | Turkey | Austria | |
| Chemotherapy for breast cancer | from $22,500 | from $1,200 | from $15,000 |
| Chemotherapy | from $2,400 | from $2,430 | from $2,500 |
| Bone marrow transplantation | from $144,000 | from $36,000 | from $140,000 |
| Autologous bone marrow transplantation | from $58,000 | from $31,500 | from $50,000 |
| Allogenic bone marrow transplantation from an unrelated donor | from $135,000 | from $80,000 | from $180,000 |
Dr. Ram Ron is the Director of the Bone Marrow Transplantation Unit at Sourasky Medical Center's onco-hematology department.
Dr. Ron Ram has performed several hundred stem cell transplants, a key treatment for Non-Hodgkin's lymphoma, at Sourasky Medical Center (Ichilov).
Dr. El Hasid has performed over 300 bone marrow and umbilical cord blood transplants for children, heading the department at Dana Dwek Children's Hospital.
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.